106 related articles for article (PubMed ID: 322696)
1. The immunotherapy of acute myelogenous leukaemia using intravenous BCG.
Whittaker JA; Slater AJ
Br J Haematol; 1977 Feb; 35(2):263-73. PubMed ID: 322696
[TBL] [Abstract][Full Text] [Related]
2. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
[TBL] [Abstract][Full Text] [Related]
3. Active immunotherapy for the treatment of acute myelogenous leukaemia: report of two controlled trials.
Whittaker JA; Bailey-Wood R; Hutchins S
Br J Haematol; 1980 Jul; 45(3):389-400. PubMed ID: 7000149
[TBL] [Abstract][Full Text] [Related]
4. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
5. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
Powles R; Toy JL
Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
[TBL] [Abstract][Full Text] [Related]
6. Management of adult acute myelogenous leukaemia.
Crowther D; Powles RL; Bateman CJ; Beard ME; Gauci CL; Wrigley PF; Malpas JS; Fairley GH; Scott RB
Br Med J; 1973 Jan; 1(5846):131-7. PubMed ID: 4513355
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy and immunotherapy interspersion: clinical studies in acute myeloblastic leukaemia.
Whittaker JA
Recent Results Cancer Res; 1977; (62):90-4. PubMed ID: 341252
[No Abstract] [Full Text] [Related]
8. Immunotherapy maintenance in acute non-lymphocytic leukaemia.
Paton CM; Bishop JF; Mathews JD; Whiteside MG
Aust N Z J Med; 1982 Dec; 12(6):583-9. PubMed ID: 6762195
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy.
Omura GA; Vogler WR; Lefante J; Silberman H; Knospe W; Gordon D; Jarrell R
Cancer; 1982 Apr; 49(8):1530-6. PubMed ID: 7039813
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
Takemoto Y; Sampi K; Kuraishi Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
Int J Hematol; 1999 Jul; 70(1):20-5. PubMed ID: 10446490
[TBL] [Abstract][Full Text] [Related]
13. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
[TBL] [Abstract][Full Text] [Related]
14. Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.
Gutterman JU; Hersh EM; Rodriguez V; McCredie KB; Mavligit G; Reed R; Burgess MA; Smith T; Gehan E; Bodey GP; Freireich EJ
Lancet; 1974 Dec; 2(7894):1405-9. PubMed ID: 4140327
[No Abstract] [Full Text] [Related]
15. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
Mayer RJ; Davis RB; Schiffer CA; Berg DT; Powell BL; Schulman P; Omura GA; Moore JO; McIntyre OR; Frei E
N Engl J Med; 1994 Oct; 331(14):896-903. PubMed ID: 8078551
[TBL] [Abstract][Full Text] [Related]
16. Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin.
Vogler WR; Chan YK
Lancet; 1974 Jul; 2(7873):128-31. PubMed ID: 4135502
[No Abstract] [Full Text] [Related]
17. Chemoimmunotherapy for maintenance in acute myeloblastic leukemia.
Whiteside MG; Cauchi MN; Paton C; Stone J
Cancer; 1976 Oct; 38(4):1581-6. PubMed ID: 1068741
[TBL] [Abstract][Full Text] [Related]
18. FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study.
Hashmi KU; Khan B; Ahmed P; Raza S; Hussain I; Mahmood A; Iqbal H; Malik HS; Anwar M
J Pak Med Assoc; 2005 Jun; 55(6):234-8. PubMed ID: 16045091
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.
Summerfield GP; Gibbs TJ; Bellingham AJ
Br J Cancer; 1979 Nov; 40(5):736-42. PubMed ID: 389265
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
